🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find out if there is a benefit of adding He...
Status
Completed
Location
Hays Medical Center
Start Date
2009-07
Trial ID
NCT00944047
Treatments Being Tested
The aim of this study is to evaluate the effect of prolonged administration...
Status
Completed
Location
Hospital Clinic
Start Date
2008-08
Trial ID
NCT00839358
This phase II study is a randomized, placebo-controlled, double-blind study...
Status
Recruiting
Location
Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare
Start Date
2024-06-11
Trial ID
NCT06491043
Treatments Being Tested
This phase II trial studies how well onvansertib in combination with gemcit...
Status
Withdrawn
Location
OHSU Knight Cancer Institute
Start Date
2024-08-01
Trial ID
NCT06398587
This phase II trial on the assumption that abraxane and cisplatin combinati...
Status
Completed
Location
Fudan University Cancer Hospital
Start Date
2010-06
Trial ID
NCT01149798
Treatments Being Tested
Radiotherapy and chemotherapy are standard treatment of head and neck cance...
Status
Completed
Location
Centre Henri Becquerel
Start Date
2014-04
Trial ID
NCT02900963
Treatments Being Tested
This is an investigator-initiated industry-supported phase 1 clinical trial...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-11-12
Trial ID
NCT05075993
Multicenter stepped wedge cluster randomized trial of family practice clini...
Status
Unknown
Location
Medpharmgene
Start Date
2013-04
Trial ID
NCT01907958
Sepsis is a life-threatening condition characterized by organ dysfunction r...
Status
Not Yet Recruiting
Location
Istinye Üniversity
Start Date
2026-01-15
Trial ID
NCT07332715
Treatments Being Tested
This study aims to optimize neoadjuvant therapy for HER2-positive breast ca...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT06973525
Treatments Being Tested